Evidence map›Paper›PMID 27252074›Full record

ArticleIntegrative cancer therapies2017

The Chinese Herbal Mixture Tien-Hsien Liquid Augments the Anticancer Immunity in Tumor Cell-Vaccinated Mice.

Pei-Ming Yang, Jia-Ling Du, George Nian-Kae Wang, Jean-San Chia, Wei-Bin Hsu, Pin-Ching Pu, Andy Sun, Chun-Pin Chiang, Won-Bo Wang

Open access · goldAbstract read
In one paragraph

Article in Integrative cancer therapies, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Pei-Ming Yang1 College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Jia-Ling Du2 College of Medicine, National Taiwan University, Taipei, Taiwan.
George Nian-Kae Wang3 College of Pharmacy, University of Houston, Houston, Texas, USA.
Jean-San Chia4 School of Dentistry, National Taiwan University, Taipei, Taiwan.
Wei-Bin Hsu2 College of Medicine, National Taiwan University, Taipei, Taiwan.
Pin-Ching Pu2 College of Medicine, National Taiwan University, Taipei, Taiwan.
Andy Sun4 School of Dentistry, National Taiwan University, Taipei, Taiwan.
Chun-Pin Chiang4 School of Dentistry, National Taiwan University, Taipei, Taiwan.
Won-Bo Wang2 College of Medicine, National Taiwan University, Taipei, Taiwan.
National Taiwan University · TWNational Yang Ming Chiao Tung University · TWTaipei Medical University · TWUniversity of Houston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Chinese herbal mixture, Tien-Hsien liquid (THL), has been used as an anticancer dietary supplement for more than 20 years. Our previous studies have shown that THL can modulate immune responseand inhibit tumor growth. In this study, we further evaluated the effect of THL on anticancer immune response in mice vaccinated with γ-ray-irradiated tumor cells.

methodsThe antitumor effect of THL was determined in mice vaccinated with low-tumorigenic CT-26-low colon cancer cells or γ-ray-irradiated high-tumorigenic CT-26-high colon cancer cells. The number of natural killer (NK) cells and T lymphocytes in the spleen was analyzed by flow cytometry. The tumor-killing activities of NK cells and cytotoxic T lymphocytes (CTLs) were analyzed by flow cytometry using YAC-1 and CT-26-high cells, respectively, as target cells. The levels of IFN-γ, IL-2, and TNF-α were determined by ELISA.

resultsTHL suppressed the growth of CT-26-high tumor in mice previously vaccinated with low-tumorigenic CT-26-low cells or γ-irradiated CT-26-high cells. THL increased the populations of NK cells and CD4+ T lymphocytes in the spleen and enhanced the tumor-killing activities of NK cells and CTL in mice vaccinated with γ-irradiated CT-26-high cells. THL increased the production of IFN-γ, IL-2, and TNF-α in mice vaccinated with γ-irradiated CT-26-high cells.

conclusionTHL can enhance the antitumor immune responses in mice vaccinated with killed tumor cells. These results suggest that THL may be used as a complementary medicine for cancer patients previously treated with killed tumor cell vaccines, radiotherapy, or chemotherapy.

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorColonic NeoplasmsDrugs, Chinese HerbalFemaleImmunityInterferon-gammaInterleukin-2Killer Cells, NaturalMiceMice, Inbred BALB CT-Lymphocytes, CytotoxicTumor Necrosis Factor-alphaAntineoplastic AgentsDrugs, Chinese HerbalInterferon-gammaInterleukin-2tien-hsien liquidTumor Necrosis Factor-alphaanticancer immunitycytotoxic T lymphocyteherbal mixtureinterferon-γinterleukin-2natural killer cellTien-Hsien liquidtumor necrosis factor αtumor suppression

Identifiers

PMID27252074
PMCPMC5759942
OpenAlexW2409088845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.